as on October 4, 2025 at 1:29 am IST
Day's Low
Day's High
-0.10%
Downside
2.89%
Upside
52 Week's Low
52 Week's High
35.60%
Downside
2.84%
Upside
Check Amneal Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.3B
EPS (TTM)
0.7666
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
2.61%
PE Ratio (TTM)
1039
Industry PE ratio
8.355964912280701
P/B Ratio
1039
PEG Ratio
0EBITDA
625.2M
Revenue (TTM)
2.9B
Profit Margin
0.12%
Return On Equity TTM
-881.26%
Track how Amneal Pharmaceuticals Inc. P/E has moved over time to understand its valuation trends.
Amneal Pharmaceuticals Inc. in the last 5 years
Lowest (2.93x)
March 31, 2023
Industry (8.36x)
October 4, 2025
Today (1039.00x)
October 4, 2025
Highest (21.89x)
September 30, 2025
Today’s Price to Earnings Ratio: 1039.00x
Compare market cap, revenue, PE, and other key metrics of Amneal Pharmaceuticals Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $3.3B | 156.54% | 1039 | 0.12% | |
BUY | $20.5B | NA | 17.68 | 40.36% | |
BUY | $39.9B | NA | 19.73 | 13.81% | |
BUY | $13.6B | 44.85% | 40.54 | 13.88% | |
BUY | $64.9B | -10.47% | 25.16 | 27.83% |
The Amneal Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Amneal Pharmaceuticals Inc. investment value today
Current value as on today
₹1,25,773
Returns
₹25,773
(+25.77%)
Returns from Amneal Pharmaceuticals Inc. Stock
₹20,000 (+20%)
Dollar Returns*
₹5,773 (+5.77%)
Based on 11 analysts
81.82%
Buy
9.09%
Hold
9.09%
Sell
Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Amneal Pharmaceuticals Inc.. Average target price of $12.5
Get share price movements and forecasts by analysts on Amneal Pharmaceuticals Inc..
What analysts predicted
16.96%UPSIDE
Target Price
$12.5
Current Price
$10.38
Analyzed by
11 Analysts
Target
$12.50
Amneal Pharmaceuticals Inc. target price $12.5, a slight upside of 16.96% compared to current price of $10.38. According to 11 analysts rating.
Search interest for Amneal Pharmaceuticals Inc. Stock has decreased by -8% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 24 September
Wed, 04:06 PM
-J.P. Morgan maintains Buy rating on AMRX, citing strong product momentum and growth prospects despite insider selling.
Wed, 05:24 PM
-Amneal Pharmaceuticals receives FDA approval for generic LUMIGAN, enhancing its position in the ophthalmic generics market.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 3 quarters, -31.08M → 22.41M (in $), with an average increase of 200.2% per quarter
Revenue Rich
Revenue is up for the last 2 quarters, 695.42M → 724.50M (in $), with an average increase of 4.0% per quarter
Price Rise
In the last 3 years, AMRX stock has moved up by 395.5%
Best in 3 Years
In the last 3 years, AMRX has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
In the last 1 year, Neurocrine Biosciences Inc. has given 23.2% return, outperforming this stock by 6.7%
Organisation | Amneal Pharmaceuticals Inc. |
Headquarters | 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807 |
Industry | Health Technology |
CEO | Mr. Chirag K. Patel |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Gregory Sgammato | Senior Vice President of Corporate Development |
Mr. Chirag K. Patel | Co-Founder, Co-CEO, President & Director |
Mr. Chintu Patel R.Ph. | Co-Founder, Co-CEO & Director |
Mr. Jason B. Daly Esq. | Executive VP, Chief Legal Officer & Corporate Secretary |
Mr. Andrew S. Boyer | Executive VP and Chief Commercial Officer of Generics & Biosciences |
Mr. Anthony DiMeo | Head of Investor Relations |
Mr. Anastasios G. Konidaris | Executive VP & CFO |
Ms. Nikita Shah | Executive VP & Chief Human Resources Officer |
Mr. Pranav Mehta | Senior VP of Strategic Sourcing & Supply Management |
Dr. Sanjay Kumar Jain Ph.D. | Chief Quality Officer |
Amneal Pharmaceuticals Inc. share price today is $10.38 as on at the close of the market. Amneal Pharmaceuticals Inc. share today touched a day high of $10.68 and a low of $10.39.
Amneal Pharmaceuticals Inc. share touched a 52 week high of $10.68 on and a 52 week low of $6.69 on . Amneal Pharmaceuticals Inc. stock price today i.e. is closed at $10.38,which is 2.76% down from its 52 week high and 55.27% up from its 52 week low.
Amneal Pharmaceuticals Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Amneal Pharmaceuticals Inc. (AMRX) shares with as little as ₹88.775 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.75 in Amneal Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Amneal Pharmaceuticals Inc. share’s latest price of $10.38 as on October 4, 2025 at 1:29 am IST, you will get 0.9634 shares of Amneal Pharmaceuticals Inc.. Learn more about
fractional shares .
Amneal Pharmaceuticals Inc. stock has given 156.54% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?